P. Imbach

Adolescents and young adults with newly diagnosed primary immune thrombocytopenia
20236 citationsauthor #14
Understanding Immune Thrombocytopenia: Looking Out of the Box
202120 citationsauthor #6
Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.
202122 citationsauthor #3
Immune Thrombocytopenia (ITP): Current Limitations in Patient Management
202053 citationsauthor #6
Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group
20191 citationsauthor #5
Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group.
20198 citationsauthor #5
Manual of Intravenous and Subcutaneous IgG Indications in Autoimmune Diseases
20181 citationsauthor #1
The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation
20181 citationsauthor #1
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants
201868 citationsauthor #5
Analysis of Children with Secondary ITP an Observational Study of Children of the Parc-ITP Registry of the Intercontinental Cooperative ITP Study Group (ICIS)
20180 citationsauthor #3
Antibody Therapy: Substitution – Immunomodulation – Monoclonal Immunotherapy
20181 citationsauthor #1
Manual of Primary and Secondary Immunodeficiencies
20180 citationsauthor #1
A comparative prospective observational study of children and adults with immune thrombocytopenia: 2‐year follow‐up
201858 citationsauthor #5
5th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Flüeli-Ranft, Switzerland, September 2015.
20162 citationsauthor #1
Soft Tissue Sarcomas
20140 citationsauthor #1
Germ Cell Tumors
20140 citationsauthor #1
Non-Hodgkin-Lymphom
20140 citationsauthor #1
[Immune thrombocytopenia -- onkopedic guidelines update: recommendations of a joint working group of the DGHO, ÖGHO, SGH + SSH and GPOH].
20147 citationsauthor #4
Advances in the management of ITP in children and adults.
20141 citationsauthor #1
Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group.
2013241 citationsauthor #11
4th Intercontinental Cooperative ITP Study Group (ICIS) expert meeting in Montreux, Switzerland, September 2012.
20131 citationsauthor #2
Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions
201318 citationsauthor #2
thrombocytopenic purpura Severe hemorrhage in children with newly diagnosed immune
20130 citationsauthor #8
Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review.
201250 citationsauthor #1
"Despite the difficulty in defining the multiple and complex mechanisms of action of intravenous immuno gobulin, this biological drug - be it transiently or for long‑term benefit - became essential for many patients ..."
20120 citationsauthor #1
30 years of immunomodulation by intravenous immunoglobulin.
201214 citationsauthor #1
Soft Tissue Sarcoma
20111 citationsauthor #1
General Aspects of Childhood Leukemia
20115 citationsauthor #1
Comprar Pediatric oncology. A comprehensive guide | R. Arceci | 9783642203589 | Springer
20113 citationsauthor #3
Nephroblastoma (Wilms Tumor)
20112 citationsauthor #1
Oxidative stress may cause ITP.
20117 citationsauthor #1
Thrombopoietin-receptor agonists for primary immune thrombocytopenia.
201162 citationsauthor #1
Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group
2011149 citationsauthor #11
primary immune thrombocytopenia International consensus report on the investigation and management of
20100 citationsauthor #7
Editorial 3rd Intercontinental Cooperative ITP Study Group (ICIS) Expert Meeting in Basel, Switzerland, September 2009
20105 citationsauthor #2
Biologic Immunotherapy with Human Intravenous Immunoglobulin Ivig in Inflammatory and Autoimmune Disorders: Experiences During the Last 30 Years
20100 citationsauthor #1
Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders
201065 citationsauthor #1
International consensus report on the investigation and management of primary immune thrombocytopenia.
20101,915 citationsauthor #14
Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia
20109 citationsauthor #2
Future research in ITP: an ICIS consensus
20107 citationsauthor #3
Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
201024 citationsauthor #8
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
20092,578 citationsauthor #16
an international working group immune thrombocytopenic purpura of adults and children: report from Standardization of terminology, definitions and outcome criteria in
20090 citationsauthor #16
Bleeding manifestations and management of children with persistent and chronic immune thrombocytopenia: data from the Intercontinental Cooperative ITP Study Group (ICIS).
2009111 citationsauthor #3
Day hospital versus inpatient management: An economic initiative of a pediatric center, examplified on uncomplicated vaso‐occlusive crises of children with sickle cell disease
20086 citationsauthor #1
Immunopathogenesis, Immunomodulation and Management of Immune Thrombocytopenic Purpura in Children
20080 citationsauthor #1
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura.
2008180 citationsauthor #3
Evans syndrome and idiopathic thrombocytopenic purpura in families: Consider autoimmune lymphoproliferative disease
20086 citationsauthor #3
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Commentary
20080 citationsauthor #4
Splenectomy in children with idiopathic thrombocytopenic purpura: A prospective study of 134 children from the Intercontinental Childhood ITP Study Group
200799 citationsauthor #9
Idiopathic Thrombocytopenic Purpura
20071 citationsauthor #1
Acute Myelogenous Leukemia
20060 citationsauthor #1
Childhood ITP: 12 months follow‐up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS)
2006195 citationsauthor #1
Pediatric oncology: A comprehensive guide
200624 citationsauthor #1
2nd ICIS Expert Meeting 2006 on critical issues and future development of research in ITP
20063 citationsauthor #3
Non-Hodgkin Lymphoma (NHL)
20065 citationsauthor #1
Development and research in idiopathic thrombocytopenic purpura: An inflammatory and autoimmune disorder
20069 citationsauthor #1
Idiopathic thrombocytopenic purpura (ITP): Is there a genetic predisposition?
200639 citationsauthor #2
Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity
200529 citationsauthor #1
Childhood leukaemia in Switzerland: Comparison of different sources of data
20054 citationsauthor #3
Non-Hodgkin-Lymphom (NHL)
20040 citationsauthor #1
Nephroblastom (Wilms-Tumor)
20040 citationsauthor #1
[Idiopathic thrombocytopenic purpura in children].
200436 citationsauthor #1
Splenectomy in childhood idiopathic thrombocytopenic purpura: Results of the splenectomy registry.
20033 citationsauthor #9
Overview of the State of the Art Expert Meeting of the Intercontinental Childhood ITP Study Group (ICIS).
20036 citationsauthor #1
Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences.
2003166 citationsauthor #6
Splenectomy in childhood idiopathic thrombocytopenic purpura
20030 citationsauthor #9
Local and Cultural Aspects of Childhood Idiopathic Thrombocytopenic Purpura: A Summary of Statements from the 12 Countries Worldwide (see Appendix)
200319 citationsauthor #1
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
2003287 citationsauthor #7
Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
200310 citationsauthor #1
New Developments in Idiopathic Thrombocytopenic Purpura (ITP): Cooperative, Prospective Studies by the Intercontinental Childhood ITP Study Group
200311 citationsauthor #1
Refractory Idiopathic Immune Thrombocytopenic Purpura in Children
200314 citationsauthor #1
Historical Aspects and Present Knowledge of Idiopathic Thrombocytopenic Purpura
200242 citationsauthor #1
Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.
2001273 citationsauthor #2
[Improved treatment results in children with AML: Results of study AML-BFM 93].
200116 citationsauthor #10
Polymorphisms in inflammatory cytokines and Fcγ receptors in childhood chronic immune thrombocytopenic purpura: a pilot study
2001104 citationsauthor #10
Ethnicity and Environment May Affect the Phenotype of Immune Thrombocytopenic Purpura in Children
200028 citationsauthor #5
PEDIATRIC HEMATOLOGY AND ONCOLOGY AT THE UNIVERSITY CHILDREN'S HOSPITAL, BASEL, SWITZERLAND
20000 citationsauthor #4
[Single and double high-dose chemotherapy with autologous stem cell transplantation in children with advanced solid tumors: first experiences].
20003 citationsauthor #6
Sequelae of treatment of ITP with anti-D (Rho) immunoglobulin.
20007 citationsauthor #1
#151 HLA mismatched sibling donor peripheral stem cell transplantation in a 10-year-old boy with multiple relapsed acute myeloid leukemia
19990 citationsauthor #4
Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-year-old girl with von Willebrand disease type 3.
19997 citationsauthor #2
SPLENECTOMY REGISTRY IN CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA
19990 citationsauthor #2
Chronic Immune Thrombocytopenic Purpura in Childhood
199813 citationsauthor #2
Management of children with acute and chronic immune thrombocytopenic purpura.
19988 citationsauthor #2
[Establishing an umbilical cord blood bank for unrelated allogenic stem cell transplantation].
19986 citationsauthor #11
605 Persistent severe thrombocytopenia with late in vitro megakaryocyte responsiveness to thrombopoietin in a child with the thrombocytopenia with absent radii (TAR) syndrome
19970 citationsauthor #4
Correction: Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children (Current Opinion in Pediatrics (1997) February (35-40))
19970 citationsauthor #1
Immunologic aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children
199725 citationsauthor #1
International study to compare antigen‐specific methods used for the measurement of antiplatelet autoantibodies
199787 citationsauthor #12
DIAGNOSIS AND MANAGEMENT OF CHILDHOOD CHRONIC ITP 12
19971 citationsauthor #1
Immune Thrombocytopenia in Children: The Immune Character of Destructive Thrombocytopenia and the Treatment of Bleeding
199513 citationsauthor #1
Immunoglobulin Subclass Concentration in Preterm Infants Treated Prophylactically with Different Intravenous Immunoglobins
19953 citationsauthor #3
Boys but Not Girls with T‐Lineage Acute Lymphocytic Leukemia (ALL) Are Different from Children with B‐Progenitor ALL: Population‐Based Data Results of Initial Prognostic Factors and Long‐Term Event‐Free Survival
199510 citationsauthor #1
Incidence of childhood acute lymphoblastic leukemia (ALL) and population-based treatment results in Switzerland: experiences with 507 study and 149 nonstudy patients.
19954 citationsauthor #3
Childhood NHL in Switzerland: incidence and survival of 120 study and 42 non-study patients.
199560 citationsauthor #10
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
1994320 citationsauthor #5
Harmful and beneficial antibodies in immune thrombocytopenic purpura.
199421 citationsauthor #1
All-trans retinoic acid as an alternative to chemotherapy in the treatment of acute promyelocytic leukemia.
19932 citationsauthor #2
Diffusion of immunoglobulins into rabbit cornea after subconjunctival injection: Experimental demonstration and mathematical model
199313 citationsauthor #3

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT